Boehringer Ingelheim expands COVID-19 collaborations

By The Science Advisory Board staff writers

April 8, 2020 -- Boehringer Ingelheim announced that it is significantly increasing support for the fight against COVID-19, particularly by adding a number of strategic collaboration partners for therapy development.

Since January, the company has designated over 100 expert research and development scientists to contribute to projects for potential treatment solutions for COVID-19. The company has established additional collaborations with academia, biotech, and other pharmaceutical companies.

  • Boehringer Ingelheim is committing over 11,000 hours in R&D to the Innovative Medicines Initiative.
  • The company has also joined forces with the Bill & Melinda Gates Foundation COVID-19 Therapeutics Acceleration.
  • Six of the company's antiviral compounds and 43 pharmacological tool compounds have been shared on the open innovation portal opnMe.com.

Additionally, Boehringer Ingelheim has made available $6.4 million in donations for emergency aid. The company is also offering paid leave to join external organizations to bring COVID-19 relief.

Committed to further contributions as needed, the company is working in broad strokes to tackle the virus, according to Cyrille Kuhn, PhD, executive director of research at Boehringer Ingelheim.

AI engine analyzes over 50,000 novel coronavirus papers
Clinical artificial intelligence (AI) software developer Mendel said it has developed an AI-based search engine that can analyze more than 50,000 novel...
Applied DNA, Takis expand COVID-19 vaccine development
Applied DNA and Takis Biotech have added a fifth candidate to their COVID-19 vaccine development program, increasing the chances of a successor emerging.
Dante Labs offers free whole-genome sequencing services to scientists
Dante Labs, an Italy-based commercial genomics laboratory, announced it has started a program to support global scientific research on the novel coronavirus....

Copyright © 2020 scienceboard.net


Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
Email
Conferences
Festival of Genomics & Biodata
January 28-29, 2021
London, Greater London United Kingdom
Lab of the Future USA
May 11-12, 2021
Boston, Massachusetts United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter